{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:10:13Z","timestamp":1773922213699,"version":"3.50.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.clon.2008.12.011","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T03:24:43Z","timestamp":1235273083000},"page":"343-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement"],"prefix":"10.1016","volume":"21","author":[{"given":"J.D.","family":"Fenwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.I.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.V.","family":"Eswar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Q.","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2008.12.011_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","article-title":"Continuous hyper-fractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial","volume":"350","author":"Saunders","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2008.12.011_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0360-3016(92)90568-3","article-title":"Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe","volume":"23","author":"Maher","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0936-6555(05)80850-7","article-title":"Audit: the use of radiotherapy for NSCLC in the UK","volume":"5","author":"Maher","year":"1993","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib4","series-title":"The physics of three-dimensional radiation therapy","author":"Webb","year":"1993"},{"key":"10.1016\/j.clon.2008.12.011_bib5","series-title":"Radiation oncology advances","article-title":"Advances in intensity-modulated radiotherapy delivery","author":"Fenwick","year":"2008"},{"key":"10.1016\/j.clon.2008.12.011_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.semradonc.2007.08.001","article-title":"Image-guided radiation therapy: from concept to practice","volume":"17","author":"Jaffray","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.semradonc.2007.07.003","article-title":"Different styles of image-guided radiotherapy","volume":"17","author":"van Herk","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/srao.2000.9279","article-title":"Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer","volume":"10","author":"Liengswangwong","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/srao.2000.9613","article-title":"Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation","volume":"10","author":"Williams","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0360-3016(02)03028-6","article-title":"Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrence in a phase II study of induction chemotherapy and involved-field radiotherapy","volume":"54","author":"Senan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2005.06.043","article-title":"Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional radiotherapy?","volume":"64","author":"Giraud","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0360-3016(00)01374-2","article-title":"A new approach to dose-escalation in non-small-cell lung cancer","volume":"49","author":"Mehta","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/JCO.2001.19.3.705","article-title":"73.6Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer","volume":"19","author":"Maguire","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/clon.2002.0121","article-title":"Dose-escalation with CHARTWEL (Continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer","volume":"14","author":"Saunders","year":"2002","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0360-3016(03)01385-3","article-title":"Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I\/II dose escalation clinical trial","volume":"57","author":"Wu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2004.07.033","article-title":"Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET\/CT imaging with induction chemotherapy for patients with non-small-cell lung cancer","volume":"73","author":"Holloway","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2003.09.006","article-title":"Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional radiation therapy","volume":"71","author":"Thirion","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2004.04.013","article-title":"Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer","volume":"3","author":"Rengan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib20","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/cncr.21007","article-title":"Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma","volume":"103","author":"Rosenzweig","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: a phase I\u2013II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2006.04.034","article-title":"Final results of a phase I\/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy","volume":"66","author":"Belderbos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijrobp.2006.01.051","article-title":"Final toxicity results of a dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictions for radiation pneumonitis and fibrosis","volume":"65","author":"Kong","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2006.02.046","article-title":"Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer","volume":"65","author":"Schild","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(97)01907-5","article-title":"Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer","volume":"44","author":"Armstrong","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0360-3016(95)00227-8","article-title":"Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?","volume":"34","author":"Krol","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0169-5002(99)00087-2","article-title":"Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer","volume":"26","author":"Hayakawa","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0360-3016(00)00667-2","article-title":"Involved-field radiotherapy alone for early stage non-small-cell lung cancer","volume":"48","author":"Cheung","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijrobp.2005.06.029","article-title":"Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?","volume":"64","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2006.09.047","article-title":"Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer","volume":"67","author":"Christian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0360-3016(03)00743-0","article-title":"Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation","volume":"57","author":"Grills","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000421-200302000-00014","article-title":"Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements","volume":"26","author":"Scrimger","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ijrobp.2003.09.086","article-title":"Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer","volume":"58","author":"Murshed","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ijrobp.2003.09.085","article-title":"Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer","volume":"58","author":"Liu","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2005.02.011","article-title":"Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer","volume":"62","author":"Schwartz","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijrobp.2005.01.028","article-title":"Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimisation technique","volume":"63","author":"Chapet","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2006.07.009","article-title":"Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes","volume":"80","author":"Chapet","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib38","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1088\/0031-9155\/47\/13\/302","article-title":"Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation","volume":"47","author":"Bortfeld","year":"2002","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2008.12.011_bib39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1088\/0031-9155\/48\/12\/307","article-title":"An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments","volume":"48","author":"Jiang","year":"2003","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2008.12.011_bib40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1118\/1.2192908","article-title":"Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study","volume":"33","author":"Duan","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-8140(02)00377-8","article-title":"First results of a phase I\/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy","volume":"66","author":"Belderbos","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0360-3016(94)E0021-B","article-title":"A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients","volume":"31","author":"Ball","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(96)00353-7","article-title":"High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost treatment of nonsmall cell lung cancer: unusual toxicity and promising results","volume":"36","author":"King","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(98)00196-5","article-title":"Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients","volume":"42","author":"Kwa","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0360-3016(00)00454-5","article-title":"Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer","volume":"47","author":"Seppenwoolde","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","article-title":"Comparing different models that predict the incidence of radiation pneumonitis","volume":"55","author":"Seppenwoolde","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(03)00195-6","article-title":"Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue","volume":"69","author":"de Jaeger","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(02)02929-2","article-title":"Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional radiation therapy","volume":"54","author":"Yorke","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib49","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2005.03.026","article-title":"Correlations of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study","volume":"63","author":"Yorke","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib50","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2006.07.1337","article-title":"Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)","volume":"66","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0360-3016(01)01685-6","article-title":"Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer","volume":"51","author":"Hernando","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2004.02.066","article-title":"Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?","volume":"61","author":"Miller","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1118\/1.595312","article-title":"Models in radiotherapy: volume effects","volume":"10","author":"Schultheiss","year":"1983","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(91)90068-R","article-title":"The simultaneous boost technique: the concept of relative normalised total dose","volume":"22","author":"Lebesque","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib55","series-title":"Basic clinical radiobiology","article-title":"The linear-quadratic model in clinical practice","author":"Bentzen","year":"2002"},{"key":"10.1016\/j.clon.2008.12.011_bib56","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0360-3016(01)02731-6","article-title":"Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame","volume":"52","author":"Nagata","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semradonc.2005.12.003","article-title":"Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastasis","volume":"16","author":"Kavanagh","year":"2006","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semradonc.2005.12.002","article-title":"Stereotactic body radiation therapy for extracranial oligometastasis: does the sword have a double edge?","volume":"16","author":"Sampson","year":"2006","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib59","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumours in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00066-007-1724-z","article-title":"Stereotactic single-dose radiotherapy of lung metastasis","volume":"183","author":"Hof","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2008.12.011_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0360-3016(99)00183-2","article-title":"Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)","volume":"45","author":"Graham","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0360-3016(97)00343-X","article-title":"Physical and biological predictors of changes in whole-lung function following thoracic irradiation","volume":"39","author":"Marks","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ijrobp.2004.11.013","article-title":"Use of principal components analysis to evaluate the partial organ tolerance of normal tissues to radiation","volume":"62","author":"Dawson","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib64","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0167-8140(93)90264-9","article-title":"Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation","volume":"26","author":"Yorke","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-8140(98)00019-X","article-title":"Dose\u2013effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer","volume":"48","author":"Theuws","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-8140(89)90009-1","article-title":"Radiation-induced lung damage: dose-time-fractionation considerations","volume":"14","author":"van Dyk","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/095530000138448","article-title":"Quantitative clinical radiobiology of early and late lung reactions","volume":"76","author":"Bentzen","year":"2000","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.clon.2008.12.011_bib68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijrobp.2004.04.037","article-title":"Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer","volume":"60","author":"Seppenwoolde","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib69","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/clon.2002.0117","article-title":"From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome","volume":"14","author":"Bentzen","year":"2002","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-8140(94)90019-1","article-title":"Dose\u2013effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma","volume":"32","author":"Boersma","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib71","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1148\/radiol.2213992043","article-title":"Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer","volume":"221","author":"Rosen","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2008.12.011_bib72","first-page":"319","article-title":"An \u2018incomplete-repair\u2019 model for survival after fractionated and continuous irradiations","volume":"47","author":"Thames","year":"1985","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.clon.2008.12.011_bib73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0167-8140(90)90006-I","article-title":"Early and late effects of fractionated irradiation and the kinetics of repair in rat lung","volume":"17","author":"van Rongen","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib74","series-title":"AAPM Report 85: tissue inhomogeneity corrections for megavoltage photon beams","author":"AAPM Task Group 64","year":"2004"},{"key":"10.1016\/j.clon.2008.12.011_bib75","first-page":"90","article-title":"Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer","volume":"9","author":"Choy","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib76","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1053\/j.seminoncol.2005.03.011","article-title":"Treatment-related esophagitis","volume":"32","author":"Werner-Wasik","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(99)00087-0","article-title":"Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre study","volume":"52","author":"Saunders","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0360-3016(93)90964-W","article-title":"A phase I\/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07","volume":"26","author":"Byhardt","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib79","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.1998.16.11.3518","article-title":"Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593","volume":"16","author":"Mehta","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(99)00093-6","article-title":"A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial","volume":"52","author":"Ball","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-8140(03)00231-7","article-title":"Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules","volume":"69","author":"Fowler","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-8140(95)01689-9","article-title":"Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy","volume":"38","author":"Bentzen","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0360-3016(01)02721-3","article-title":"Radiation-induced changes in cellularity and proliferation in human oral mucosa","volume":"52","author":"D\u00f6rr","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijrobp.2008.02.008","article-title":"Early mucosal reactions during and following head and neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration","volume":"71","author":"Fenwick","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0360-3016(99)00163-7","article-title":"Clinical and dosimetric predictors of radiation-induced esophageal toxicity","volume":"45","author":"Maguire","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib86","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0360-3016(00)00699-4","article-title":"Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy","volume":"48","author":"Werner-Wasik","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(01)01648-0","article-title":"Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin\/paclitaxel radiotherapy","volume":"51","author":"Hirota","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0360-3016(02)03937-8","article-title":"Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy","volume":"55","author":"Singh","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib89","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2004.04.051","article-title":"Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery","volume":"60","author":"Patel","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib90","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ijrobp.2004.10.042","article-title":"\u2018Anatomically-correct\u2019 dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics","volume":"62","author":"Kahn","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib91","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ijrobp.2004.12.025","article-title":"Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy","volume":"62","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2005.04.004","article-title":"Dosimetric correlates of acute esophagitis in lung cancer patients treated with radiotherapy","volume":"62","author":"Takeda","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib93","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.03.021","article-title":"Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy","volume":"75","author":"Belderbos","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib94","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ijrobp.2005.11.022","article-title":"Multivariate modelling of radiotherapy outcomes, including dose-volume and clinical factors","volume":"64","author":"El-Naqa","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib95","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2006.04.022","article-title":"Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy","volume":"66","author":"Wei","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib97","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-8140(99)00133-4","article-title":"Clinical radiation doses for spinal cord: the 1998 international questionnaire","volume":"55","author":"Fowler","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib98","series-title":"Radiopathology of organs and tissues","article-title":"The nervous system: radiobiology and experimental pathology","author":"van der Kogel","year":"1991"},{"key":"10.1016\/j.clon.2008.12.011_bib99","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-8140(92)90249-T","article-title":"Impact of spinal cord repair kinetics on the practice of altered fractionation schedules","volume":"25","author":"Ang","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0167-8140(92)90303-C","article-title":"Fractionation response and repair kinetics of radiation induced heart failure in the rat","volume":"23","author":"Schultz-Hector","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0167-8140(92)90304-D","article-title":"Late radiation response of canine mediastinal tissues","volume":"23","author":"McChesney Gillette","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-5002(99)00019-7","article-title":"Estimation of tumor control probability model parameters from 3-D distributions of non-small cell lung cancer patients","volume":"24","author":"Martel","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib103","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1088\/0031-9155\/43\/8\/012","article-title":"Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression","volume":"43","author":"Fenwick","year":"1998","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2008.12.011_bib104","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijrobp.2004.01.004","article-title":"Loss of biological effect in prolonged fraction delivery","volume":"59","author":"Fowler","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clon.2007.11.003","article-title":"Optimum overall times II: extended modelling for head and neck radiotherapy","volume":"20","author":"Fowler","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib106","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionation or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2008.12.011_bib107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.coc.0000139486.24747.26","article-title":"Induction chemotherapy with carboplatin\u2013paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer","volume":"28","author":"Ardizzoni","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib108","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/bjc.1998.474","article-title":"Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer","volume":"78","author":"Yokoyama","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jjco\/hye106","article-title":"Randomized phase 1 study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of the Japan Clinical Oncology Group Study (JCOG 9601)","volume":"31","author":"Tsuchiya","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib110","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib111","first-page":"621","article-title":"Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable stage III NSCLC: RTOG 9410","volume":"22","author":"Curran","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib112","first-page":"691","article-title":"A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer","volume":"95","author":"Pierre","year":"2001","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clon.2008.12.011_bib113","first-page":"290a","article-title":"Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized phase II study","volume":"21","author":"Zatloukal","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002140.pub2","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","author":"Rowell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2008.12.011_bib115","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0360-3016(03)00345-6","article-title":"In regard to Tsujino et\u00a0al.: predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoirradiation for lung cancer","volume":"56","author":"Seppenwoolde","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1349-7006.2004.tb03331.x","article-title":"Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer","volume":"95","author":"Sekine","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clon.2008.12.011_bib117","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00066-007-1593-5","article-title":"6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer","volume":"192","author":"Semrau","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2008.12.011_bib118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2002.03.054","article-title":"Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B study 9431","volume":"20","author":"Vokes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib119","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique \u2013 Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie NPC 95-01 study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2008.12.011_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lungcan.2005.05.020","article-title":"Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo\/radiation therapy for locally advanced non-small cell lung cancer","volume":"50","author":"Kim","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib121","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.lungcan.2004.08.010","article-title":"Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie","volume":"47","author":"Vergnen\u00e8gre","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib122","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ijrobp.2007.11.028","article-title":"Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial","volume":"71","author":"van Baardwijk","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib123","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/1097-0142(197309)32:3<547::AID-CNCR2820320306>3.0.CO;2-4","article-title":"Radiation pneumonitis: a new approach to the derivation of time-dose factors","volume":"32","author":"Wara","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2008.12.011_bib124","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0360-3016(94)00475-Z","article-title":"Radiation dose-response of human tumors","volume":"32","author":"Okunieff","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2008.12.011_bib125","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1158\/1078-0432.CCR-03-0248","article-title":"Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy","volume":"10","author":"Buffa","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:53Z","timestamp":1760542493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655509000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0936655509000302"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2008.12.011","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2008.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}